- Palabras clave > access to maternal/RH medicines
- Palabras clave > assessment
- Palabras clave > availability - children’s medicines
- Palabras clave > emergency obstetric medicines - management
- Palabras clave > maternal and child health - MCH
- Palabras clave > maternal, newborn, and child health commodities
- Palabras clave > medicines for maternal and child health
- Palabras clave > obstetric care
- Palabras clave > obstetrics and gynaecology
- Palabras clave > pharmaceutical management
(2012; 70 pages)
Ngabo, F., J. Briggs, F. Sayinzoga, D. Mutamba, G.I. Buki, M. Wathum, and J. Nyirimigabo. 2012. Rapid Assessment of Pharmaceutical Management of Medicines and Supplies for Preventing and Managing Emergency Obstetric and Newborn Conditions in Rwanda: September 2012. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.
This USAID-funded rapid assessment, which was initiated by the Strengthening Pharmaceutical Systems Program and then continued under the SIAPS Program seeks to determine the availability and management of maternal and newborn health (MNH) pharmaceuticals, building on information obtained through the LMIS, the recent Maternal and Child Health Integrated Program (MCHIP) national level multicountry study, and the Quality of Care Survey (MCHIP 2011).
The rapid assessment was conducted in 10 districts of Rwanda in a sample of 60 health facilities, including district pharmacies (DPs), district hospitals (DHs), and health centers (HCs) plus the central medical store Medicines Procurement and Distribution Division (MPDD) to evaluate pharmaceutical management of medicines and commodities for preventing and managing maternal and newborn emergency conditions, in particular postpartum hemorrhage (PPH), pre-eclampsia and eclampsia (PE/E), and maternal and newborn sepsis. The data collectors conducted observations and interviews with storekeepers and personnel in charge of the delivery suite, and in addition, data were gathered from key informants at the central level. The aspects assessed in the survey included selection and quantification, the supply chain (i.e., order process and frequency, stock management, record-keeping, storage conditions, and availability), knowledge of standard treatment guidelines (STGs), reporting, training and supervision, and a comparison of sales and purchase prices of the tracer medicines.